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A B S T R A C T
Background: Sublingual nitroglycerin capsules or spray is routinely used to treat anginal attacks and to
maximally dilate the epicardial coronary arteries during coronary angiography. These dilated coronary
vessels have an advantage, but increased heart rates were disadvantageous for coronary computed
tomography angiography (CTA).
Purpose: The inﬂuence of applying nitroglycerin was analyzed regarding the coronary diameter,
coronary luminal attenuation, evaluable number of coronary segments, heart rate (HR), HR variability,
the optimal reconstruction phase, and image scoring of CTA in the same patients using a 64-slice dual-
source CT.
Methods and subjects: Fifty-two patients with atypical chest pain underwent coronary CTA before and
after the administration of sublingual nitroglycerin without heart rate control. The coronary diameter
and luminal attenuation were measured on short-axial images in each coronary segment. The coronary
vasodilation ratios (VRs) were calculated from the coronary diameters at the same location before and
after the use of nitroglycerin. The local institutional review board approved this study and written
informed consent was obtained from all the patients.
Results: No signiﬁcant differences were noted in the HR variability or optimal reconstruction phase,
despite an increase in HR after the use of nitroglycerin. Nitroglycerin signiﬁcantly enlarged the coronary
artery diameter, and VRs of each coronary segment ranged from 7.54% to 22.26%. As compared with
baseline coronary diameter, VRs of minor segments (16.91%) were signiﬁcantly larger than those of
major segments (11.35%), and the magnitude of VR correlated with the baseline coronary diameter
(r = 0.48, p < 0.001). Coronary luminal attenuation signiﬁcantly increased due to additional
administration of contrast material after the use of nitroglycerin (p < 0.01), but no signiﬁcant difference
was noted in the image quality after the use of nitroglycerin.
Conclusion: Sublingual nitroglycerin signiﬁcantly enlarged the coronary diameters, especially in
peripheral small coronary arteries, and increased the evaluable number of coronary segments on
coronary CTA.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Coronary computed tomography angiography (CTA) has evolved
into a reliable, noninvasive technique to detect or rule out signiﬁcant* Corresponding author at: Department of Radiology, Yamaguchi University
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightscoronary artery stenosis [1,2]. The current generation of multi-
detector-row CT (MDCT) systems permits the cross-sectional and
longitudinal imaging of the coronary arteries with a high spatial and
temporal resolution. However, small vessels and side branches and
the distal portions of the main coronary arteries are not always
optimally visualized [3,4]. Before coronary CTA, sublingual nitroglyc-
erin is usually used to dilate the coronary vessels. The investigators of
several studies on coronary CTA using MDCT reported that the use of
nitroglycerin is now a widely accepted practice to dilate the coronary reserved.
Fig. 1. Volume rendering coronary computed tomography angiography (CTA) images before and after the use of nitroglycerin. Coronary CTA images before (A) and after (B)
the administration of sublingual nitroglycerin showing the more dilated septal, diagonal, high lateral, and right ventricular branches following the nitroglycerin
administration.
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angiography [8], intravascular ultrasound [9], or magnetic resonance
angiography [10]. Impaired coronary vasodilation in response to
nitroglycerin, an endothelium-independent vasodilator, has been
found in patients who have coronary risk factors [11] and has also
been associated with an increased risk of future cardiac events [12].
In this study, the effects of sublingual administration of
nitroglycerin on coronary CTA were evaluated in the same patients
using 64-slice dual-source CT (DSCT) without heart rate control
(Fig. 1). The coronary diameter and mean attenuation were
measured in the same coronary segments before and after the
administration of nitroglycerin. Vasodilation ratios (VRs) were
calculated and compared with the baseline cross-sectional
coronary diameters. The image quality of coronary CTA was also
evaluated by two readers before and after the administration of
sublingual nitroglycerin.
Materials and methods
Between August 2010 and November 2011, ﬁfty-two patients (15
males and 37 females, mean age: 65.9  9.6 years, age range: 36–77
years, mean body weight: 56.3  9.3 kg, body mass index:
23.0  3.4 kg/m2) suspected to have atypical chest pain were
prospectively included in this study (Table 1) and underwent
electrocardiogram (ECG)-gated coronary CTA before and after the
use of nitroglycerin (twice in the same examination) using 64-slice
DSCT (Somatom Deﬁnition, Siemens Healthcare, Forchheim, Germany).Table 1
The patients’ characteristics.
Mean SD Range
Age (years) 65.9 9.6 36–77
Gender (percentage of male) 28.9 45.8 Male = 15, female = 37
Body weight (kg) 56.3 9.3 41–78
BMI (kg/m2) 23 3.4 14.7–33.8
Creatine (mg/dl) 0.7 0.16 0.44–1.05
BUN (mg/dl) 16.84 18.05 7–22.5
eGFR (ml/min/1.73 m2) 73.3 16 45.5–119.5
Diastolic BP before CTA (mmHg) 78 11.6 45–108
Systolic BP before CTA (mmHg) 152.4 22.9 115–209
Diastolic BP after CTA (mmHg) 70.9 10.3 51–94
Systolic BP after CTA (mmHg) 136.4 17 112–172
The normal range of creatine (0.64–1.12 mg/dl [male], 0.48–0.81 mg/dl
[female]).
BUN, blood urea nitrogen (normal range: 8–23 mg/dl); eGFR, estimated
glomerular ﬁltration rate; SD, standard deviation; BP, blood pressure; CTA,
computed tomography angiography; BMI, body mass index.To reduce the radiation exposure, unenhanced CT was omitted.
However, two scans of coronary CTA even under wide ECG-dependent
dose modulation (25–85%) in the same examination might lead to
increased radiation exposure. Wide ECG-dependent dose modulation
was applied, because there was a possibility that the optimal
reconstruction windows might shift from diastolic to systolic phase
as HR increased without HR control. The local institutional review
board approved this study, and written informed consent was obtained
from each patient. This study aimed to evaluate the difference of
coronary vasodilation in the patients with atypical chest pain and as a
baseline study, the coronary vasodilation was compared with its
diameter in detail. The patients suspected to have typical effort angina
or with a previous history of percutaneous coronary intervention or
coronary artery bypass graft surgery were excluded from the study.
Scan protocol
Vasoactive medications were discontinued 24 h before the
examination. An unenhanced calcium scoring scan was omitted to
reduce the radiation exposure. Coronary CTA before the use of
nitroglycerin was performed by using a 64-slice DSCT scanner and
the scan volume was determined from the tracheal bifurcation to
the base of the heart with the ECG-dependent dose modulation
from 25% to 85% of the RR interval. One minute after the coronary
CTA scan without nitroglycerin, nitroglycerin was sublingually
atomized using a nitroglycerin pump spray (one push of 0.3 mg of
atomized nitroglycerin; Myocorspray, Astellas, Tokyo, Japan). Four
minutes after the administration of nitroglycerin, coronary CTA
scan with nitroglycerin started at the same time after the injection
of contrast material. The interval of coronary CTA before and after
the administration of nitroglycerin was about 5 min. The
parameters of coronary CTA were the same and as follows:
number of X-ray tubes, 2; collimation, 32 detector rows of 0.6 mm
each, with double sampling by using rapid alteration of the focal
spot in the longitudinal direction (z ﬂying focal spot); rotation
time, 330 ms; tube voltage, 120 kV; and full tube current, 625 mA
(independent of the patient size). Prior to scanning, the pitch was
set automatically by the scanner software program.
A bolus of iodinated contrast material (300 mgI/ml, Ominipa-
que; Daiich-Sankyo, Tokyo, Japan), which varied between 40 ml
and 70 ml, depending on the expected scan time  ﬂow rate, was
injected at a ﬂow rate of 0.07 (ml/s/kg)  body weight (kg), in the
right antecubital vein, followed by a saline chaser (30 ml; same
ﬂow rate as the contrast material). The region of interest (ROI) was
placed at the ascending aorta and the bolus-tracking technique
based on real-time monitoring of the main bolus during injection
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mAs) monitoring scans was used.
CT image reconstruction
All coronary CTA images were reconstructed using a single-
segment reconstruction algorithm, resulting in temporal resolu-
tion of 83 ms, section thickness of 0.75 mm, and an increment of
0.4 mm, and medium-to-smooth (B26f) convolution kernels.
Standard reconstruction algorithms were applied by using an
absolute reverse or percentage technique to obtain data sets during
end systole and/or mid-to-end diastole according to the HR
frequency [13]. When the standard reconstruction algorithm
provided data sets with insufﬁcient image quality of one or more
coronary segments, additional data sets were manually recon-
structed. These data were reconstructed in 5% steps throughout the
R–R interval. Two independent physicians selected the optimal
reconstruction phase to minimize the motion or banding artifact of
each major coronary vessel – the right coronary artery, left anterior
descending artery, and left circumﬂex artery based on axial or
curved multiplanar reformation (MPR) images.
Analysis of MDCT angiograms
MDCT data were transferred from the scanner to an ofﬂine
workstation (Ziostation, Ziosoft, Tokyo, Japan) for postprocessing and
analysis. To measure the same coronary position, the measurement
position was decided from the same coronary branch, such as #7 from
septal branch or #13 from #12 and so on. However, if there were
coronary plaques at these sites, the coronary diameter was measured
at the same distance away from these plaques. The short axial
diameters of each coronary segment were measured according to the
American Heart Association guidelines [14] and performed in a plane
perpendicular to curved MPR images along the long axis of the vessel
using a workstation. A two-dimensional proﬁle measuring attenua-
tion along a line crossing through the lumen was made on a vessel
cross-sectional image. Plot proﬁles of the coronary diameter were
analyzed using the Image J semiautomatic image processing software,
written in Java, which allows it to run on Linux, Mac OS X, and
Windows operating systems, in both 32-bit and 64-bit modes,
without a license (http://rsb.info.nih.gov/ij/). In this study, the
coronary diameter was not deﬁned as an internal luminal diameter,
but an outer luminal one calculated as an average of horizontal and
vertical coronary diameter with the attenuation over 10 Hounsﬁeld
units (HU) in each coronary proﬁle. The evaluable coronary diameter
was deﬁned as the diameter more than 1 mm using our measurement
method and tiny branches with low luminal attenuation were
excluded from this study.
The luminal attenuation at the same coronary site was measured
before and after the use of nitroglycerin in the center of coronary
lumen of each segment (within 5 mm) using a ﬁxed ROI of 1.0 mm2,
from #1 to #15, including the high lateral branch. As the equivalent
attenuation, the mean attenuation and noise (SD) of ascending aorta
was also measured. The two board-certiﬁed observers (with 15 and 6
years of experience, respectively), blinded to the use of nitroglycerin,
independently evaluated the image quality scoring of each coronary
vessel using a 3-point scale (0 = not assessed, and doubling or
discontinuity in the course of the coronary artery preventing
diagnostic evaluation; 1 = fair, moderate artifacts, moderate blurring
with structure discontinuity; 2 = good, minor artifacts, mild blurring
of the segment; and 3 = excellent, no motion artifacts).
Statistical analysis
All analyses were performed and graphs were made with the
PASW statistical software program (version 18; SPSS, Tokyo,Japan). The quantitative variables were expressed as mean-
s  standard deviation (SD), and categorical variables were expressed
as frequencies or percentages. Differences with a p value <0.05 were
considered to be statistically signiﬁcant.
The differences in patient’s characteristics, coronary diameter,
and coronary luminal attenuation were compared by the use of
nitroglycerin using the paired Student’s t test by segment (#1–#15,
including high lateral branch), vessel [right coronary artery (RCA),
left coronary artery including left main trunk (LCA), left circumﬂex
artery (LCx)], major (#1–3, #5–7, #11, #13) or minor segment
(#4PD, #4PL, #8–10, #12, #14, #15), and patient-basis. Image
scoring was also compared between the two readers using the
paired t test, and the interobserver variability for the image quality
of coronary CTA before and after the use of nitroglycerin was
determined by calculating intraclass correlation coefﬁcients (ICC).
The strength of agreement was interpreted as slight (ICC < 0.20),
fair (ICC = 0.21–0.40), moderate (ICC = 0.41–0.60), good
(ICC = 0.61–0.80), or excellent (ICC = 0.81–1.0) [15].
Results
All subjects completed the study without any complications.
Nitroglycerin caused a small but signiﬁcant systemic effect, and
there was a 10.6% decrease in systolic blood pressure (from
152.4  22.9 mmHg to 136.4  17.0 mmHg), 9.1% decrease in dia-
stolic blood pressure (from 78.0  11.6 mmHg to 70.9  10.3 mmHg)
(Table 1), 6.5% increase in HR (from 72.2  16.3 beats/min to
76.9  15.5 beats/min, p < 0.001), and 23.36% decrease in HR
variability (from 13.1  20.2 beats/min to 10.0  18.5 beats/min,
p = 0.19) (Table 2). With the signiﬁcant increase in HR by the use
of nitroglycerin, the optimal reconstruction phase of the right and left
coronary arteries on coronary CTA was slightly shifted from the
diastolic (the percentage of diastolic reconstruction: 50.0% in RCA and
50.0% in LCA) to the systolic phase (the percentage of diastolic
reconstruction: 44.2% in RCA and 46.2% in LCA) in both coronary
arteries after the use of nitroglycerin, but there was no signiﬁcant
difference in the optimal reconstruction phase of coronary CTA. The
radiation doses using dose length product (DLP, mGy cm) signiﬁcant-
ly decreased after the use of nitroglycerin (p = 0.04), but no signiﬁcant
difference was noted in those using the CT dose index volume
(CTDIvol, mGy) by use of nitroglycerin (Table 2).
The VR of each segment is listed in Table 3, and ranged from
7.54% (#5) to 22.26% (high lateral branch) and the mean VR on
coronary CTA was 13.84% when sublingual nitroglycerin was used.
The VR in minor segments (16.91  13.83%) was larger than that in
major segments (11.35  9.72%), and a higher correlation was noted
between the baseline cross-sectional diameter and VR (r = 0.52,
p < 0.001) in minor segments (Table 4). The patient-based analysis
showed a moderate correlation between the VR and baseline cross-
sectional coronary diameter (r = 0.48, p < 0.001) (Fig. 2). The VR was
smaller in the LAD, including the left main trunk (11.97  11.59%),
but a higher correlation was noted in the LAD (r = 0.53) than in the
RCA (0.46) or LCx (r = 0.38) (Table 4). With regard to the baseline
cross-sectional diameter, the mean diameter of the LAD was similar to
that of the RCA, but the ratios of evaluable coronary segments and VR
were lower in the LAD than those in the RCA, because the LAD
included more small branches, such as #8, #9, and #10 (Table 3). The
low VR of #5 and #6 with large coronary diameters also have led to
the low VR of the LAD.
The evaluable segmental number was lower at the coronary
luminal attenuation than that of coronary diameter (Tables 3 and 5),
because the small coronary branch did not have a large enough
lumen to place the ROI, even using a small ﬁxed ROI (1.0 mm2). The
mean attenuation of the coronary lumen signiﬁcantly increased and
the SD of the coronary lumen decreased after the administration of
nitroglycerin (Table 5), but there was no difference between mean
Table 3
The coronary diameters and vasodilation ratio by the use of nitroglycerin.
Number of evaluable coronary segments Diameter of each coronary segment Vasodilation ratio (%)
Before nitroglycerin number (%) After nitroglycerin number (%) Before nitroglycerin After nitroglycerin p value
Mean (SD) Mean (SD)
#1 52 (100.0) 52 (100.0) 3.82 (0.69) 4.34 (0.72) <0.001** 11.70
#2 51 (98.1) 51 (98.1) 3.60 (0.68) 4.08 (0.65) <0.001** 11.75
#3 50 (96.2) 51 (98.1) 3.17 (0.67) 3.65 (0.69) <0.001** 13.31
#4PD 46 (88.5) 47 (90.4) 2.03 (0.51) 2.57 (0.63) <0.001** 20.58
#4PL 46 (88.5) 47 (90.4) 2.38 (0.57) 2.76 (0.55) 0.002** 13.9
#5 52 (100.0) 52 (100.0) 4.61 (0.86) 4.98 (0.80) 0.026* 7.54
#6 52 (100.0) 52 (100.0) 3.88 (0.66) 4.21 (0.63) 0.010* 7.71
#7 50 (96.2) 51 (98.1) 3.30 (0.56) 3.67 (0.49) 0.001** 12.25
#8 52 (100.0) 52 (100.0) 2.47 (0.53) 2.85 (0.50) <0.001** 12.83
#9 43 (82.7) 47 (90.4) 2.02 (0.55) 2.38 (0.55) 0.003** 17.2
#10 32 (61.5) 34 (65.4) 1.94 (0.52) 2.29 (0.55) 0.010** 15.6
#11 51 (98.1) 52 (100.0) 3.03 (0.66) 3.52 (0.70) <0.001* 14.33
#12 32 (61.5) 34 (65.4) 1.98 (0.54) 2.35 (0.56) 0.008** 17.96
#13 50 (96.2) 51 (98.1) 2.61 (0.48) 3.07 (0.61) <0.001** 14.43
#14 44 (84.6) 46 (88.5) 1.86 (0.38) 2.30 (0.49) <0.001** 18.21
#15 28 (53.9) 32 (61.6) 1.86 (0.44) 2.20 (0.44) <0.001** 17.34
HL 18 (34.6) 19 (36.6) 1.79 (0.52) 2.22 (0.59) 0.024* 22.26
All segments 749 (84.7) 770 (87.1) 2.86 (1.40) 3.26 (1.46) <0.001** 13.84
SD, standard deviation.
* p = <0.05.
** p = <0.01.
Table 4
The correlations between the baseline coronary diameter and vasodilation ratio.
Diameter Vasodilation ratio r p value
Mean (SD) Mean (SD)
All segments (n = 749) 2.86 (1.40) 13.84 (12.07) 0.48 <0.001**
Major segments (n = 408) 3.51 (0.99) 11.35 (9.72) 0.46 <0.001**
Minor segments (n = 341) 2.08 (1.04) 16.91 (13.83) 0.52 <0.001**
RCA (n = 245) 3.04 (1.15) 14.12 (11.87) 0.46 <0.001**
LAD (including LMT) (n = 281) 3.06 (1.59) 11.97 (11.59) 0.53 <0.001**
LCx (including HL) (n = 223) 2.35 (1.15) 16.16 (12.57) 0.38 <0.001**
Major segments include #1, #2, #3, #5, #6, #7, #11 and #13. Minor segments include #4PD, #4PL, #8, #9, #10,HL, #12, #14 and #15.
RCA, right coronary artery; LAD, left anterior descending artery; LMT, left main trunk; LCx, left circumﬂex artery; HL, high lateral branch.
** p = <0.01.
Table 2
The heart rate, heart rate variability, reconstruction window, and radiation exposure during coronary computed tomography angiography by the use of nitroglycerin.
Before the use of nitroglycerin After the use of nitroglycerin p value
Mean (SD) Mean (SD)
Heart rate (beats/min) 72.2 (16.3) 76.9 (15.5) <0.001**
Heart rate variability (beats/min) 13.1 (20.2) 10.0 (18.5) 0.19
Reconstruction phase of RCA in R–R interval (%) 57.8 (17.3) 55.7 (16.4) 0.26
Percentage of diastolic reconstruction in RCA (%) 50.0% 44.2% 0.56
Reconstruction phase of LCA in R–R interval (%) 58.2 (17.5) 55.5 (17.8) 0.15
Percentage of diastolic reconstruction in LCA (%) 50.0% 46.2% 0.7
Number of evaluable segments 749 (84.7) 770 (87.1) 0.24
CTDIvol (mGy) 63.6 (16.0) 59.4 (14.6) 0.26
DLP (mGy cm) 1057.5 (280.2) 959.5 (252.5) 0.04*
Total amount of contrast material (ml) 57.4 (10.1) 56.8 (10.9) 0.81
RCA, right coronary artery; LCA, left coronary artery including left main trunk; CTDIvol, computed tomography dose index volume; DLP, dose length product; SD, standard
deviation.
* p = <0.05.
** p = <0.01.
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of contrast material (Table 5). Increased attenuation ratio was larger
in peripheral segments than in major proximal segments, and larger
in RCA than in LCA (Table 5).
High image scoring was provided in both coronary CTAs
regardless of nitroglycerin in this study. The patient-based analysis
showed no signiﬁcant differences in the coronary CTA images
using DSCT related to the use of nitroglycerin and good to excellentagreements were achieved on image scoring between the two
readers by the patient- and vessel-based analysis (ICC ranging from
0.65 to 0.81, p < 0.001) (Table 6).
Discussion
Nitroglycerin has been used to demonstrate endothelium-inde-
pendent vasodilation as a positive control for endothelium-dependent
Fig. 2. The correlation between the baseline cross-sectional diameters and
vasodilation ratios. The vasodilation ratio had a moderate correlation with the
baseline cross-sectional coronary diameter (r = 0.48, p < 0.001).
M. Okada et al. / Journal of Cardiology 65 (2015) 230–236234vasodilation, and some previous studies have shown that an impaired
vasodilatory response to nitroglycerin is associated with risk factors
for coronary artery disease [11] and with an increase in future events
[12]. Nitrates increase the coronary blood ﬂow in the epicardial
coronary arteries by vasodilation [8,16] and have an important effect
on the diameter of the coronary arteries, especially on the size of
nonstenotic segments, and have a lesser effect on stenotic segments.Table 5
The luminal attenuation before and after the use of nitroglycerin.
Mean attenuation 
Mean (SD)
Before nitroglycerin n After nit
Aorta 324.7 (48.5) 52 323.2 (5
All segments 276.8 (86.8) 732 315.4 (7
Major segments 313.4 (72.8) 407 338.7 (6
Minor segments 234.4 (82.3) 325 288.5 (7
RCA 275.9 (88.7) 244 335.7 (8
LAD (including LMT) 284.3 (84.3) 275 308.9 (7
LCx 266.9 (87.4) 213 300.5 (7
Major segments include #1,#2, #3, #5, #6, #7, #11 and #13. Minor segments includ
RCA, right coronary artery; LCA, left coronary artery; LAD, left anterior descending a
* p = <0.05.
** p = <0.01.
Table 6
The interobserver variability of coronary computed tomography angiography by the u
Reader 1 Reader 2 
Mean (SD) Mean (SD) 
Patient
Before nitroglycerin 2.79 (0.53) 2.79 (0.59) 
After nitroglycerin 2.90 (0.36) 2.86 (0.47) 
RCA
Before nitroglycerin 2.65 (0.62) 2.65 (0.71) 
After nitroglycerin 2.87 (0.40) 2.79 (0.61) 
LCA
Before nitroglycerin 2.92 (0.39) 2.89 (0.38) 
After nitroglycerin 2.94 (0.31) 2.92 (0.27) 
RCA, right coronary artery; LCA, left coronary artery; SD, standard deviation; ICC, int
** p = <0.01.As a result, nitrates can enhance the detection of obstructive lesions
[17,18].
In this study, patients with atypical chest pain were included
and those with effort angina were excluded, so the ratio of females
was high (71.1%). With the use of nitroglycerin, HR was
signiﬁcantly increased, but there was no signiﬁcant difference
between the optimal reconstruction phases of coronary CTA before
and after the administration of nitroglycerin in the same patients
using 64-slice DSCT, because of its ﬁne temporal resolution
(83 ms). The differences in HR, systolic, and diastolic blood
pressures were larger in this study among the same patients than
those in a previous study using different patient groups [7]. HR
variability tended to be lower after the administration of
nitroglycerin, and lower HR variability was associated with higher
diagnostic accuracy of 64-MDCT coronary angiography [19].
A moderate correlation was achieved between the VR and cross-
sectional coronary diameter by the patient-, vessel-, and segment-
basis (Table 4), but the VRs of the small branches were larger than
those of the large vessels. In consideration of the spatial resolution of
CT, coronary CTA might not be sufﬁcient to evaluate the small
coronary branches, because in the imaging of the coronary tree with
CTA, tiny branches (i.e. <1–2 mm) were usually excluded from
analysis, at least in earlier studies [3,4,20]. However, the overall size
of the coronary arteries is small on coronary CTA, so every attempt to
enhance the size and increase enhancement should be made [4];
therefore, nitroglycerin resulted in an important vasodilatory
response for coronary CTA. In addition, the number of evaluable
coronary segments increased after the use of nitroglycerin, and
especially enhanced the small branches (Table 3). However, in this
study the evaluable coronary diameter was deﬁned as an outer
luminal diameter more than 1 mm and tiny branches with low
luminal attenuation were excluded from this study. The diameters of
tiny branches were underestimated from the point of CT spatialIncreased attenuation (%) p value
roglycerin n
7.0) 52 0.5 0.81
7.5) 749 13.9 <0.001**
7.8) 412 8.1 0.001**
9.4) 337 23.1 0.004**
0.2) 247 21.7 0.03*
4.5) 282 8.7 <0.001**
4.0) 220 12.6 <0.001**
e #4PD,#4PL,#8,#9,#10,HL, #12, #14 and #15.
rtery; LMT, left main trunk; LCx, left circumﬂex artery.
se of sublingual nitroglycerin.
ICC 95% CI p value
Lower Upper
0.81 0.74 0.87 <0.001**
0.75 0.66 0.83 <0.001**
0.83 0.72 0.9 <0.001**
0.78 0.65 0.87 <0.001**
0.74 0.59 0.84 <0.001**
0.65 0.47 0.79 <0.001**
erclass correlation; CI, conﬁdence interval.
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contrast material might also enhance the luminal attenuation and
affect the number of evaluable coronary segments after the use of
nitroglycerin. Sublingual nitroglycerin, at a dose of 0.4 mg, induces a
vasodilatory response within 2–5 min with maximal effects at 3–
15 min and there is little residual activity after 20–30 min [21,22].
The scanning of the coronary CTA with nitroglycerin was started
about 5 min after the administration of nitroglycerin in this study.
The use of sublingual nitroglycerin spray instead of another nitrate
preparation was based on the previous literature stating that
sublingual nitroglycerin spray may be more efﬁcacious than other
nitrates and may cause fewer side effects [23], which are often seen
with the other routes of administration [24].
The coronary luminal attenuation was signiﬁcantly higher after
the use of nitroglycerin (Table 5) and increased luminal attenua-
tion might affect the measurement of coronary diameter on
coronary CTA. However, the coronary diameter was deﬁned as the
outer distance of coronary arteries with more than 10 HU to reduce
the effect of increased coronary luminal attenuation in this study.
Despite increased HR, no signiﬁcant difference was noted in the
optimal reconstruction phase (Table 2) and the image qualities
before and after the administration of nitroglycerin (Table 6).
However, the assessable coronary segments increased in small
vessels after the administration of nitroglycerin (84.7% vs 87.1%)
(Table 3). The interobserver variability of coronary CTA with the
use of sublingual nitroglycerin was good to excellent by the two
readers and no signiﬁcant differences of image quality with the use
of nitroglycerin were noted in the RCA of reader 1 (Table 6). In this
study, nitroglycerin worked as the vasodilator, but additional
contrast material also affected the coronary luminal attenuation
after the use of nitroglycerin.
There were a few limitations associated with this study that must
be acknowledged. We did not investigate the inﬂuence of the
sublingual nitroglycerin spray on the diagnostic accuracy for the
detection of signiﬁcant lesions (stenosis > 75% lumen diameter), or of
calciﬁed or soft plaque lesions, because this study explored only the
capacity of the sublingual nitroglycerin spray to enlarge the lumen
size. For the calculation of coronary diameter, the full width at half
maximum (FWHM) technique could be used from the half value
between peaks and valleys of the coronary proﬁle curve, but
additional contrast material enhanced the coronary lumen and
previous contrast material enhanced the vessel wall, coronary
plaques, or surrounding fat. In consideration of the spatial resolution
of CT and lower luminal attenuation of small coronary branches,
FWHM might be insufﬁcient for the small coronary vessels. Scanning
patients twice with contrast materials in the same day was not
feasible because of the radiation exposure and high total iodine of the
contrast material, so unenhanced CT for measurement of the coronary
artery calcium scoring was omitted and ECG-dependent dose
modulation was used to reduce radiation exposure. An estimation
of effective radiation dose can be derived by weighting the DLP
according to the region scanned, using a factor of 0.014 for the chest
[25]. In this study, total estimated effective radiation dose of both
scans was about 28.2 mSv and exceeded the recommended radiation
dose of 20 mSv [26], but in consideration of omitting ECG-gated
unenhanced CT for measurement of the coronary artery calcium
scoring, total radiation dose was not so high as compared with that
mentioned in the Society of Cardiovascular Computed Tomography
guideline [26]. However, further patient’s care for radiation exposure
might be needed. The patients also received contrast material twice in
the same study, but we used a medium (300 mgI/ml) iodinated
contrast material instead of a high iodinated contrast material. The
amount of contrast material on both coronary CTAs was less than
120 ml in this study (Table 2), but we thought that the total amount of
contrast material was not excessive in consideration of the patients’
body weight and renal function (Table 1).Conclusion
Sublingual nitroglycerin spray signiﬁcantly enlarged the coro-
nary lumen, especially in peripheral segments, and increased the
evaluable number of coronary segments without diminishing the
image quality, despite signiﬁcant increase of HR.
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